Download
s00401-021-02382-4.pdf 1,39MB
WeightNameValue
1000 Titel
  • EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma
1000 Autor/in
  1. , |
  2. Camgöz, Aylin |
  3. Pfister, Stefan M. |
  4. Kool, Marcel |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-11-11
1000 Erschienen in
1000 Quellenangabe
  • 143(1):1-13
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00401-021-02382-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732814/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Ependymomas (EPN) are tumors of the central nervous system (CNS) that can arise in the supratentorial brain (ST-EPN), hindbrain or posterior fossa (PF-EPN) or anywhere in the spinal cord (SP-EPN), both in children and adults. Molecular profiling studies have identified distinct groups and subtypes in each of these anatomical compartments. In this review, we give an overview on recent findings and new insights what is driving PFA ependymomas, which is the most common group. PFA ependymomas are characterized by a young median age at diagnosis, an overall balanced genome and a bad clinical outcome (56% 10-year overall survival). Sequencing studies revealed no fusion genes or other highly recurrently mutated genes, suggesting that the disease is epigenetically driven. Indeed, recent findings have shown that the characteristic global loss of the repressive histone 3 lysine 27 trimethylation (H3K27me3) mark in PFA ependymoma is caused by aberrant expression of the enhancer of zeste homolog inhibitory protein (EZHIP) or in rare cases by H3K27M mutations, which both inhibit EZH2 thereby preventing the polycomb repressive complex 2 (PRC2) from spreading H3K27me3. We present the current status of the ongoing work on EZHIP and its essential role in the epigenetic disturbance of PFA biology. Comparisons to the oncohistone H3K27M and its role in diffuse midline glioma (DMG) are drawn, highlighting similarities but also differences between the tumor entities and underlying mechanisms. A strong focus is to point out missing information and to present directions of further research that may result in new and improved therapies for PFA ependymoma patients.
1000 Sacherschließung
lokal Female [MeSH]
lokal DMG
lokal PFA ependymoma
lokal Ependymoma/genetics [MeSH]
lokal Humans [MeSH]
lokal Oncogene Proteins/genetics [MeSH]
lokal EZHIP
lokal H3K27M
lokal H3K27me3
lokal Male [MeSH]
lokal PRC2
lokal Infratentorial Neoplasms/genetics [MeSH]
lokal Review
lokal Child [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-2689-9937|https://frl.publisso.de/adhoc/uri/Q2FtZ8O2eiwgQXlsaW4=|https://frl.publisso.de/adhoc/uri/UGZpc3RlciwgU3RlZmFuIE0u|https://frl.publisso.de/adhoc/uri/S29vbCwgTWFyY2Vs
1000 Hinweis
  • DeepGreen-ID: 5717c2eedf5844e8b08831fb415e87dd ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6450688.rdf
1000 Erstellt am 2023-05-11T10:26:22.703+0200
1000 Erstellt von 322
1000 beschreibt frl:6450688
1000 Zuletzt bearbeitet 2023-10-20T09:11:29.014+0200
1000 Objekt bearb. Fri Oct 20 09:11:29 CEST 2023
1000 Vgl. frl:6450688
1000 Oai Id
  1. oai:frl.publisso.de:frl:6450688 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source